Luca Cantini
Impact in
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- Inflammatory Biomarkers in Disease Prognosis
-
- Occupational and environmental lung diseases
- Inhalation and Respiratory Drug Delivery
- Lung Cancer Treatments and Mutations
Papers in
- Oncology 44
- Cancer Immunotherapy and Biomarkers 12
- Pancreatic and Hepatic Oncology Research 7
- Lung Cancer Research Studies 7
- COVID-19 and healthcare impacts 6
-
- Inhalation and Respiratory Drug Delivery 13
- Occupational and environmental lung diseases 12
- Lung Cancer Treatments and Mutations 8
- Co-authors
- Rossana BerardiJoachim G.J.V. AertsFederica PecciRiccardo GiampieriDaniel H. StermanR ChioinP.A. Monici PretiMarco Balducelli
- Journals
- Annals of Oncology (10 papers)Journal of Thoracic Oncology (5 papers)Drugs in Context (3 papers)European Journal of Cancer (2 papers)Cancers (2 papers)
- Partner nations
- ItalyNetherlandsUnited States
In The Last Decade
Luca Cantini
72 papers receiving 781 citations
Peers
Comparison fields: 5 of 90
- Oncology 330
- Pulmonary and Respiratory Medicine 351
- Cancer Research 117
- Immunology and Allergy 47
- Otorhinolaryngology 26
Countries citing papers authored by Luca Cantini
This map shows the geographic impact of Luca Cantini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luca Cantini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luca Cantini more than expected).
Fields of papers citing papers by Luca Cantini
This network shows the impact of papers produced by Luca Cantini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luca Cantini. The network helps show where Luca Cantini may publish in the future.
Co-authors
The 25 scholars most cited alongside Luca Cantini, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2023 | 16 | |
| 3 | 2022 | 10 | |
| 4 | 2021 | 1 | |
| 5 | 2021 | 1 | |
| 6 | 2021 | 31 | |
| 7 | 2021 | 1 | |
| 8 | 2020 | 2 | |
| 9 | 2019 | 10 | |
| 10 | 2019 | 0 | |
| 11 | 2018 | 3 | |
| 12 | 2018 | 14 | |
| 13 | 2017 | 3 | |
| 14 | 2017 | 1 | |
| 15 | 2016 | 1 | |
| 16 | 2003 | 41 | |
| 17 | 2002 | 4 | |
| 18 | Equivalent efficacy and safety of a new HFA-134a formulation of BDP compared with the conventional CFC in adult asthmatics. | 2002 | 11 |
| 19 | Inhaled beclomethasone dipropionate administered through a new spacer device: a controlled clinical study. | 1996 | 1 |
| 20 | 1993 | 1 |
About Luca Cantini
Luca Cantini is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Physiology and Gastroenterology, having authored 76 papers that have together received 797 indexed citations. Recurring topics across this work include Inhalation and Respiratory Drug Delivery (13 papers), Asthma and respiratory diseases (13 papers), Occupational and environmental lung diseases (12 papers), Cancer Immunotherapy and Biomarkers (12 papers), Lung Cancer Treatments and Mutations (8 papers), Pancreatic and Hepatic Oncology Research (7 papers), Lung Cancer Research Studies (7 papers) and COVID-19 and healthcare impacts (6 papers). The work is most often cited by research in Oncology (330 citations), Pulmonary and Respiratory Medicine (351 citations), Cancer Research (117 citations), Immunology and Allergy (47 citations) and Otorhinolaryngology (26 citations). Luca Cantini has collaborated with scholars based in Italy, Netherlands and United States. Frequent co-authors include Rossana Berardi, Joachim G.J.V. Aerts, Federica Pecci, Riccardo Giampieri, Daniel H. Sterman, R Chioin, P.A. Monici Preti, Marco Balducelli, Stefano De Servi and Raffit Hassan. Their work appears in journals such as Annals of Oncology, Journal of Thoracic Oncology, Drugs in Context, European Journal of Cancer and Cancers.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.